Tanalys

Market Notice 32/25 – Information regarding the rights issue from PharmaLundensis AB

The last day of trading in the company’s shares, PHAL, including the right to receive subscription rights is February 7, 2025. The first day excluding the right to obtain the rights is February 10, 2025. 

One (1) share entitles the owner to one (1) subscription right. Seven (7) subscription rights entitle the owner to subscribe for two (2) new shares, at the price of SEK 2 (2:7 á SEK 1).   

The subscription period lasts from February 13, 2025, to February 27, 2025. 

Information about the subscription right:   
Short name: PHAL TR 
ISIN-code: SE0023875075 
Orderbook-ID: 384423 
CFI: RSSXXR 
FISN: PHARMALUND/SUBS RTS NL PD 
First day of trading: February 13, 2025 
Last day of trading: February 24, 2025 
Market Segment: SPSE 
MIC Code: XSAT 
Tick size: 2    

Information about the paid subscribed share:  
Shortname: PHAL BTA 
ISIN-code: SE0023875083 
Orderbook-ID: 384424 
CFI: ESNUFR 
FISN: PHARMALUND/SH 
Trading period: February 13, 2025 until the registration of the issue at Bolagsverket.  
Market Segment: SPSE 
MIC Code:  XSAT 
Tick size: 2    

Please be advised that if the rights issue give rise to a conversion factor, all overnight orders in the company’s order book will be flushed. If so this will occur after closing on February 7, 2025. 

Stockholm February 6, 2025 

Spotlight Stock Market 
08-51168000   
backoffice@spotlightstockmarket.com 

Exit mobile version